title: Pancreatic beta-cell alpha2A adrenoceptor and phospholipid changes in hyperlipidemic rats.
abstract: We previously showed that a 48-h intravenous lipid infusion in rats induces pancreatic beta-cell hypersensitivity to catecholamines. Our aim was to study the lipid-related changes that may account for such hypersensitivity in pancreatic islets. We show here that a 48-h increase in plasma FFA alters the binding characteristics of beta-cell alpha2 adrenoceptors in rats. Lipid infusion decreases pancreatic norepinephrine (NE) turnover rate by 28%, reflecting a reduction of pancreatic NE stores. Following lipid infusion, the density of alpha2 adrenoceptor binding sites is significantly lower and receptor affinity higher, both in islet homogenates (by three- and fivefold, respectively) and isolated whole beta-cells (by two- and sixfold, respectively). These changes correlate with the elevated insulin response to glucose found in lipid-infused rats. We also found a modification of islet phospholipid content, particularly in phosphoethanolamine species containing infused FA such as palmitate, oleate, stearate, and linoleate. This may account for the modifications in receptor affinity. These results suggest that hyperlipidemia-associated pathologies such as diabetes and obesity not only may result from alterations of metabolic pathways but also may be a consequence of early modifications in nervous firing rates and signal transduction pathways.
authors.affiliation: Laboratoire de Physiopathologie de la Nutrition, CNRS UMR 7059, Université Paris 7, France. clement@paris7.jussieu.fr
authors.forename: L
authors.initials: L
authors.lastname: Clément
authors.forename: K A
authors.initials: KA
authors.lastname: Kim-Sohn
authors.forename: C
authors.initials: C
authors.lastname: Magnan
authors.forename: N
authors.initials: N
authors.lastname: Kassis
authors.forename: P
authors.initials: P
authors.lastname: Adnot
authors.forename: M
authors.initials: M
authors.lastname: Kergoat
authors.forename: F
authors.initials: F
authors.lastname: Assimacopoulos-Jeannet
authors.forename: L
authors.initials: L
authors.lastname: Pénicaud
authors.forename: F
authors.initials: F
authors.lastname: Hsu
authors.forename: J
authors.initials: J
authors.lastname: Turk
authors.forename: A
authors.initials: A
authors.lastname: Ktorza
mesh_terms: D000818:Animals; D002395:Catecholamines / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006949:Hyperlipidemias / Q000097:blood / Q000150:complications / Q000378:metabolism*; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D018341:Receptors, Adrenergic, alpha-2 / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D021241:Spectrometry, Mass, Electrospray Ionization; D014280:Triglycerides / Q000097:blood
chemical_list: D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D010743:Phospholipids; D012333:RNA, Messenger; D018341:Receptors, Adrenergic, alpha-2; D014280:Triglycerides; D005990:Glycerol; D009638:Norepinephrine